Gisondi, P., Loconsole, F., Raimondo, P. and Ravasio, R. 2021. Cost per responder for risankizumab vs secukinumab in patients with moderate-to-severe plaque psoriasis in Italy. Global and Regional Health Technology Assessment. 8, 1 (Sep. 2021), 120–130. DOI:https://doi.org/10.33393/grhta.2021.2258.